Stock GENT GENTIAN DIAGNOSTICS
Add to a list
To use this feature you must be a member
Log inSign up

News Gentian Diagnostics

Equities

GENT

NO0010748866

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-04-23 am EDT 		5-day change 1st Jan Change
37.6 NOK +2.73% Intraday chart for Gentian Diagnostics +4.44% -9.40%
Mar. 21 Gentian Diagnostics ASA Announces Resignation of Hilja Ibert as CEO, Effective on April 29, 2024 CI
Mar. 21 Tomas Settevik Not to Stand for Re-Election as Chairperson of Gentian Diagnostics ASA, Effective April 29, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Gentian Diagnostics : Scientists to Gentian’s R&D department
PU
Gentian Diagnostics ASA Announces Resignation of Hilja Ibert as CEO, Effective on April 29, 2024
CI
Tomas Settevik Not to Stand for Re-Election as Chairperson of Gentian Diagnostics ASA, Effective April 29, 2024
CI
Gentian Diagnostics' CEO Resigns, Wins Recommendation to Succeed Chair
MT
Gentian Diagnostics ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Transcript : Gentian Diagnostics ASA, Q4 2023 Earnings Call, Feb 09, 2024
Gentian Diagnostics Asa Announces Resignation of Frank Frantzen from the Board of Directors
CI
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference
AQ
Gentian Diagnostics ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Transcript : Gentian Diagnostics ASA, Q3 2023 Earnings Call, Oct 26, 2023
Gentian Diagnostics : Sales and Application Specialist - Nordic
PU
Gentian Diagnostics ASA Expands Product Portfolio With Turbidimetric Retinol-Binding Protein Immunoassay
CI
Gentian Diagnostics ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Transcript : Gentian Diagnostics ASA, Q2 2023 Earnings Call, Aug 24, 2023
Gentian Diagnostics ASA (OB:GENT) acquired Getica Ab from Erling Sundrehagen for SEK 2.8 million.
CI
Norway's Gentian Diagnostics Buys Sweden-based Getica in SEK3 Million Deal
MT
Gentian Diagnostics ASA (OB:GENT) entered into an agreement to acquire Getica Ab from Erling Sundrehagen for SEK 3 million.
CI
Transcript : Gentian Diagnostics ASA - Analyst/Investor Day
Transcript : Gentian Diagnostics ASA, Q1 2023 Earnings Call, May 05, 2023
Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GENT Stock
  4. News Gentian Diagnostics